Table 2.
Multivariate logistic regressions comparing outcomes of hepatocellular carcinoma by race
Outcome | Race | Adjusted odds ratio | 95%CI |
Metastatic Hepatocellular Carcinoma1 | African-American | Reference | |
Caucasian | 0.82 | 0.71-0.94 | |
Hispanic | 0.87 | 0.73-1.05 | |
Other/unknown | 0.84 | 0.70-1.001 | |
Liver Decompensation2 | African-American | Reference | |
Caucasian | 1.16 | 1.03-1.30 | |
Hispanic | 1.28 | 1.10-1.51 | |
Other/unknown | 1.14 | 0.995-1.31 | |
Inpatient Mortality3 | African-American | Reference | |
Caucasian | 0.78 | 0.65-0.93 | |
Hispanic | 0.82 | 0.66-1.03 | |
Other/unknown | 0.86 | 0.69-1.07 |
Model is adjusted for age, sex, race, geographic region, hepatitis C, alcohol, non-alcoholic steatohepatitis (NASH), liver decompensation features, and Elixhauser comorbidity score;
Model is adjusted for age, sex, race, geographic region, hepatitis C, alcohol, NASH, primary biliary cirrhosis, metastasis, and Elixhauser comorbidity score;
Model is adjusted for age, sex, race, geographic region hepatitis C, hepatitis B, alcohol, NASH, liver decompensation features, metastasis, and treatment.